Zobrazeno 1 - 10
of 10
pro vyhledávání: '"IGF1R/IR inhibition"'
Autor:
Gail S. Eckhardt, Kendra M. Hasebroock, Andrea L. Merz, Todd M. Pitts, Natalie J. Serkova, Erica L. Bradshaw-Pierce
Publikováno v:
Clinical Cancer Research. 16:PR9-PR9
Colorectal cancer (CRC) represents a major health burden and accounts for nearly 10% of all cancer-related deaths in the U.S. Among the many new pathways being exploited for cancer treatment is the insulin-like growth factor receptor (IGF1R) signalin
Autor:
Natalie J. Serkova, Erica L. Bradshaw-Pierce, Kendra M. Hasebroock, Andrea L. Merz, Todd M. Pitts, Gail S. Eckhardt
Publikováno v:
Clinical Cancer Research. 16:A14-A14
This abstract is being presented as a short talk in Plenary Session 6. A full abstract is printed in the Proffered Abstracts section (PR9) of the Conference Proceedings.
Autor:
Richard J. Pietras, Yanyuan Wu, Jaydutt V. Vadgama, Rudy Sanchez, Kay Foos, Nalo Hamilton, David Austin, Brittney Chau, Diana C. Márquez-Garbán
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 11, p 2305 (2017)
International Journal of Molecular Sciences; Volume 18; Issue 11; Pages: 2305
International journal of molecular sciences, vol 18, iss 11
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 18; Issue 11; Pages: 2305
International journal of molecular sciences, vol 18, iss 11
International Journal of Molecular Sciences
Triple-negative breast cancer (TNBC) occurs in 10-15% of all breast cancer patients, yet it accounts for about half of all breast cancer deaths. There is an urgent need to identify new antitumor targets to provide additional treatment options for pat
Autor:
Wang, Qing1 (AUTHOR) qing.wang@uky.edu, Yang, Hsin-Sheng1,2 (AUTHOR) hsin-sheng.yang@uky.edu
Publikováno v:
Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1396. 12p.
Autor:
Linzer, Jason1 (AUTHOR), Phelps, Zachary1 (AUTHOR), Vummidi, Shivasuryan1 (AUTHOR), Lee, Bo Young Elizabeth1 (AUTHOR), Coant, Nicolas1 (AUTHOR), Haley, John D.1 (AUTHOR) john.haley@stonybrookmedicine.edu
Publikováno v:
Proteomes. Jun2023, Vol. 11 Issue 2, p20. 13p.
Autor:
Peterse, Elisabeth F. P.1, Cleven, Arjen H. G.1, Yvonne De Jong1, Inge Briaire-de Bruijn1, Fletcher, Jonathan A.2, Danen, Erik H. J.3, Cleton-Jansen, Anne-Marie1, Bovée, Judith V. M. G.1 J.V.M.G.bovee@lumc.nl, De Jong, Yvonne1 (AUTHOR), Briaire-de Bruijn, Inge1 (AUTHOR)
Publikováno v:
BMC Cancer. 7/14/2016, Vol. 16, p1-11. 11p. 2 Charts, 4 Graphs.
Autor:
Hamilton, Nalo1,2 nhamilton@sonnet.ucla.edu, Austin, David3 davidaustin@cdrewu.edu, Márquez-Garbán, Diana2,4 dmarquez@mednet.ucla.edu, Sanchez, Rudy5 rudy.sanchez917@myci.csuci.edu, Chau, Brittney6 chaubrittney@gmail.com, Foos, Kay7 kaymaliafoos@yahoo.com, Yanyuan Wu3 yanyuanwu@cdrewu.edu, Vadgama, Jaydutt2,3,4 jayvadgama@cdrewu.edu, Pietras, Richard3,4 rpietras@mednet.ucla.edu
Publikováno v:
International Journal of Molecular Sciences. Nov2017, Vol. 18 Issue 11, p2305. 15p.
Autor:
Patel, Hima1 (AUTHOR) patel2h2@mail.uc.edu, Mishra, Rosalin1 (AUTHOR) mishrarn@ucmail.uc.edu, Yacoub, Nour2 (AUTHOR) nyacoub@neomed.edu, Alanazi, Samar1 (AUTHOR) alanazsa@mail.uc.edu, Kilroy, Mary Kate1 (AUTHOR) kilroymk@mail.uc.edu, Garrett, Joan T.1 (AUTHOR) joan.garrett@uc.edu
Publikováno v:
Cancers. Nov2021, Vol. 13 Issue 22, p5863. 1p.
Autor:
Inge H. Briaire-de Bruijn, Elisabeth F.P. Peterse, Arjen H.G. Cleven, Anne-Marie Cleton-Jansen, Judith V.M.G. Bovée, Jonathan A. Fletcher, Yvonne de Jong, Erik H.J. Danen
Publikováno v:
BMC Cancer
BMC CANCER
BMC CANCER, 16, 475
BMC Cancer, 16
BMC CANCER
BMC CANCER, 16, 475
BMC Cancer, 16
Background Chondrosarcoma is a malignant cartilage forming bone tumour for which no effective systemic treatment is available. Previous studies illustrate the need for a better understanding of the role of the IGF pathway in chondrosarcoma to determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6933468ddeaa04fdaf8d49320ac65105
https://hdl.handle.net/1887/112588
https://hdl.handle.net/1887/112588
Autor:
Bruna Alves Fenerich, João Agostinho Machado-Neto, Eduardo Magalhães Rego, Fabiola Traina, Belinda Pinto Simões, Ana Paula Nunes Rodrigues Alves, Priscila Santos Scheucher, Jaqueline Cristina Fernandes, Fernanda Borges da Silva
Publikováno v:
ResearcherID
Background: Acute lymphoblastic leukemia (ALL) is an aggressive cancer of immature progenitors that shows aberrant activation of signaling pathways. The IGF1/IGF1R signaling pathway is initiated through binding of the ligand (IGF1) to its transmembra